Seroba is a leading European life sciences venture capital firm, dedicated to creating value by supporting innovative biotech and medtech companies. With a focus on breakthrough technologies, Seroba has backed significant advancements such as Shorla Oncology's FDA-approved TEPYLUTE, a ready-to-dilute formulation for treating breast and ovarian cancer. Based in Dublin, Seroba leverages deep industry expertise to help entrepreneurs build world-class businesses, fostering extraordinary scientific innovations.
Firms with overlapping sectors, stage and geography.
Investor focus, stage and check size change often. Confirm current details on Seroba Life Sciences's own website (seroba-lifesciences.com) before reaching out. Listing does not imply endorsement or any relationship.